Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

Table of Contents

March 1, 2012; Volume 53,Issue 3

This Month in JNM

  • You have access
    This Month in JNM
    Journal of Nuclear Medicine March 1, 2012, 53 (3) 11A-12A;

SNM Newsline

  • You have access
    Hippocrates and Certification
    Harvey Ziessman
    Journal of Nuclear Medicine March 1, 2012, 53 (3) 13N;
  • You have access
    SNM 2012 Annual Meeting in Miami
    Journal of Nuclear Medicine March 1, 2012, 53 (3) 13NA;
  • You have access
    BMD Rescreening and Procedure Overuse
    Journal of Nuclear Medicine March 1, 2012, 53 (3) 14N;
  • You have access
    Howard J. Dworkin, MD, 1932–2012
    Journal of Nuclear Medicine March 1, 2012, 53 (3) 16N;
  • You have access
    Update on CardioGen-82
    Journal of Nuclear Medicine March 1, 2012, 53 (3) 18N;
  • You have access
    SNM and AACR Announce Joint Conference
    Carolyn J. Anderson and David Piwnica-Worms
    Journal of Nuclear Medicine March 1, 2012, 53 (3) 18NA;
  • You have access
    SNM and Global Cooperation
    George Segall
    Journal of Nuclear Medicine March 1, 2012, 53 (3) 19N;
  • You have access
    Newsbriefs
    Journal of Nuclear Medicine March 1, 2012, 53 (3) 20N-21N;
  • You have access
    From the Literature
    Journal of Nuclear Medicine March 1, 2012, 53 (3) 22N-26N;

Focus on Molecular Imaging

  • You have access
    Ultrasound Microbubbles for Molecular Diagnosis, Therapy, and Theranostics
    Fabian Kiessling, Stanley Fokong, Patrick Koczera, Wiltrud Lederle and Twan Lammers
    Journal of Nuclear Medicine March 1, 2012, 53 (3) 345-348; DOI: https://doi.org/10.2967/jnumed.111.099754

Invited Perspective

  • You have access
    Looking for Myocardial Viability After a STICH Trial: Not Enough to Close the Door
    Pasquale Perrone-Filardi and Fausto J. Pinto
    Journal of Nuclear Medicine March 1, 2012, 53 (3) 349-352; DOI: https://doi.org/10.2967/jnumed.111.102210

Clinical Investigations

  • You have access
    Risk Stratification of Gallbladder Polyps (1–2 cm) for Surgical Intervention with 18F-FDG PET/CT
    Jaehoon Lee, Mijin Yun, Kyoung-Sik Kim, Jong-Doo Lee and Chun K. Kim
    Journal of Nuclear Medicine March 1, 2012, 53 (3) 353-358; DOI: https://doi.org/10.2967/jnumed.111.093948
  • You have access
    Recombinant Human Thyroid-Stimulating Hormone Versus Thyroid Hormone Withdrawal in the Identification of Metastasis in Differentiated Thyroid Cancer with 131I Planar Whole-Body Imaging and 124I PET
    Douglas Van Nostrand, Gauri R. Khorjekar, Jeff O'Neil, Shari Moreau, Frank B. Atkins, Pejman Kharazi, Mihriye Mete, Shyam P. Chennupati, Kenneth D. Burman and Leonard Wartofsky
    Journal of Nuclear Medicine March 1, 2012, 53 (3) 359-362; DOI: https://doi.org/10.2967/jnumed.111.096016
  • You have access
    Assessment of Progesterone Receptors in Breast Carcinoma by PET with 21-18F-Fluoro-16α,17α-[(R)-(1′-α-furylmethylidene)Dioxy]-19-Norpregn-4-Ene-3,20-Dione
    Farrokh Dehdashti, Richard Laforest, Feng Gao, Rebecca L. Aft, Carmen S. Dence, Dong Zhou, Kooresh I. Shoghi, Barry A. Siegel, John A. Katzenellenbogen and Michael J. Welch
    Journal of Nuclear Medicine March 1, 2012, 53 (3) 363-370; DOI: https://doi.org/10.2967/jnumed.111.098319
  • You have access
    18F-FDG PET/CT Predicts Survival After Radioembolization of Hepatic Metastases from Breast Cancer
    Alexander R. Haug, Beauclair P. Tiega Donfack, Christoph Trumm, Christoph J. Zech, Marlies Michl, Rüdiger Paul Laubender, Christopher Uebleis, Peter Bartenstein, Volker Heinemann and Marcus Hacker
    Journal of Nuclear Medicine March 1, 2012, 53 (3) 371-377; DOI: https://doi.org/10.2967/jnumed.111.096230
  • You have access
    Performance Characteristics of Amyloid PET with Florbetapir F 18 in Patients with Alzheimer's Disease and Cognitively Normal Subjects
    Abhinay D. Joshi, Michael J. Pontecorvo, Chrisopher M. Clark, Alan P. Carpenter, Danna L. Jennings, Carl H. Sadowsky, Lee P. Adler, Karel D. Kovnat, John P. Seibyl, Anupa Arora, Krishnendu Saha, Jason D. Burns, Mark J. Lowrey, Mark A. Mintun, Daniel M. Skovronsky and the Florbetapir F 18 Study Investigators
    Journal of Nuclear Medicine March 1, 2012, 53 (3) 378-384; DOI: https://doi.org/10.2967/jnumed.111.090340
  • You have access
    Brain and Whole-Body Imaging of Nociceptin/Orphanin FQ Peptide Receptor in Humans Using the PET Ligand 11C-NOP-1A
    Talakad G. Lohith, Sami S. Zoghbi, Cheryl L. Morse, Maria F. Araneta, Vanessa N. Barth, Nancy A. Goebl, Johannes T. Tauscher, Victor W. Pike, Robert B. Innis and Masahiro Fujita
    Journal of Nuclear Medicine March 1, 2012, 53 (3) 385-392; DOI: https://doi.org/10.2967/jnumed.111.097162
  • You have access
    Impact of 3,4-Dihydroxy-6-18F-Fluoro-l-Phenylalanine PET/CT on Managing Patients with Brain Tumors: The Referring Physician's Perspective
    Franziska Walter, Timothy Cloughesy, Martin A. Walter, Albert Lai, Phioanh Nghiemphu, Naveed Wagle, Barbara Fueger, Nagichettiar Satyamurthy, Michael E. Phelps and Johannes Czernin
    Journal of Nuclear Medicine March 1, 2012, 53 (3) 393-398; DOI: https://doi.org/10.2967/jnumed.111.095711
  • You have access
    Subregional Patterns of Preferential Striatal Dopamine Transporter Loss Differ in Parkinson Disease, Progressive Supranuclear Palsy, and Multiple-System Atrophy
    Minyoung Oh, Jae Seung Kim, Ji Young Kim, Kwang-Ho Shin, Seol Hoon Park, Hye Ok Kim, Dae Hyuk Moon, Seung Jun Oh, Sun Ju Chung and Chong Sik Lee
    Journal of Nuclear Medicine March 1, 2012, 53 (3) 399-406; DOI: https://doi.org/10.2967/jnumed.111.095224
  • You have access
    PET/CT Assessment of Symptomatic Individuals with Obstructive and Nonobstructive Hypertrophic Cardiomyopathy
    Paco E. Bravo, Aurélio Pinheiro, Takahiro Higuchi, Christoph Rischpler, Jennifer Merrill, Miguel Santaularia-Tomas, M. Roselle Abraham, Richard L. Wahl, Theodore P. Abraham and Frank M. Bengel
    Journal of Nuclear Medicine March 1, 2012, 53 (3) 407-414; DOI: https://doi.org/10.2967/jnumed.111.096156
  • You have access
    Clinical Validation of 18F-AZD4694, an Amyloid-β–Specific PET Radioligand
    Zsolt Cselényi, Maria Eriksdotter Jönhagen, Anton Forsberg, Christer Halldin, Per Julin, Magnus Schou, Peter Johnström, Katarina Varnäs, Samuel Svensson and Lars Farde
    Journal of Nuclear Medicine March 1, 2012, 53 (3) 415-424; DOI: https://doi.org/10.2967/jnumed.111.094029

Continuing Education

  • You have access
    Bringing Physiology into PET of the Liver
    Susanne Keiding
    Journal of Nuclear Medicine March 1, 2012, 53 (3) 425-433; DOI: https://doi.org/10.2967/jnumed.111.100214

Basic Science Investigations

  • You have access
    5-(2-18F-Fluoroethoxy)-l-Tryptophan as a Substrate of System L Transport for Tumor Imaging by PET
    Stefanie D. Krämer, Linjing Mu, Adrienne Müller, Claudia Keller, Olga F. Kuznetsova, Christian Schweinsberg, Dominic Franck, Cristina Müller, Tobias L. Ross, Roger Schibli and Simon M. Ametamey
    Journal of Nuclear Medicine March 1, 2012, 53 (3) 434-442; DOI: https://doi.org/10.2967/jnumed.111.096289
  • You have access
    3′-Deoxy-3′-18F-Fluorothymidine PET/CT to Guide Therapy with Epidermal Growth Factor Receptor Antagonists and Bcl-xL Inhibitors in Non–Small Cell Lung Cancer
    Antonella Zannetti, Francesca Iommelli, Antonio Speranza, Marco Salvatore and Silvana Del Vecchio
    Journal of Nuclear Medicine March 1, 2012, 53 (3) 443-450; DOI: https://doi.org/10.2967/jnumed.111.096503
  • You have access
    18F-FEAnGA for PET of β-Glucuronidase Activity in Neuroinflammation
    Inês F. Antunes, Janine Doorduin, Hidde J. Haisma, Philip H. Elsinga, Aren van Waarde, Antoon T.M. Willemsen, Rudi A. Dierckx and Erik F.J. de Vries
    Journal of Nuclear Medicine March 1, 2012, 53 (3) 451-458; DOI: https://doi.org/10.2967/jnumed.111.096388
  • You have access
    99mTc-Labeled Superparamagnetic Iron Oxide Nanoparticles for Multimodality SPECT/MRI of Sentinel Lymph Nodes
    Renata Madru, Pontus Kjellman, Fredrik Olsson, Karin Wingårdh, Christian Ingvar, Freddy Ståhlberg, Johan Olsrud, Jimmy Lätt, Sarah Fredriksson, Linda Knutsson and Sven-Erik Strand
    Journal of Nuclear Medicine March 1, 2012, 53 (3) 459-463; DOI: https://doi.org/10.2967/jnumed.111.092437
  • You have access
    99mTc-Labeled Tricarbonyl His-CNA35 as an Imaging Agent for the Detection of Tumor Vasculature
    Gilles Mees, Rudi Dierckx, Koen Mertens, Simon Vermeire, Magali Van Steenkiste, Chris Reutelingsperger, Yves D'Asseler, Kathelijne Peremans, Nancy Van Damme and Christophe Van de Wiele
    Journal of Nuclear Medicine March 1, 2012, 53 (3) 464-471; DOI: https://doi.org/10.2967/jnumed.111.095794
  • You have access
    Synthesis and Preliminary Evaluation of 18F-Labeled Pyridaben Analogues for Myocardial Perfusion Imaging with PET
    Tiantian Mou, Zuoquan Zhao, Wei Fang, Cheng Peng, Feng Guo, Boli Liu, Yunchuan Ma and Xianzhong Zhang
    Journal of Nuclear Medicine March 1, 2012, 53 (3) 472-479; DOI: https://doi.org/10.2967/jnumed.111.088096
  • You have access
    Experimental Radionuclide Therapy of HER2-Expressing Xenografts Using Two-Step Targeting Nuclisome Particles
    Lars Gedda, Amelie Fondell, Hans Lundqvist, John W. Park and Katarina Edwards
    Journal of Nuclear Medicine March 1, 2012, 53 (3) 480-487; DOI: https://doi.org/10.2967/jnumed.111.096891
  • You have access
    Evaluation of 4′-[Methyl-11C]Thiothymidine in a Rodent Tumor and Inflammation Model
    Jun Toyohara, Philip H. Elsinga, Kiichi Ishiwata, Jurgen W.A. Sijbesma, Rudi A.J.O. Dierckx and Aren van Waarde
    Journal of Nuclear Medicine March 1, 2012, 53 (3) 488-494; DOI: https://doi.org/10.2967/jnumed.111.098426
  • You have access
    Methods for Motion Correction Evaluation Using 18F-FDG Human Brain Scans on a High-Resolution PET Scanner
    Sune H. Keller, Merence Sibomana, Oline V. Olesen, Claus Svarer, Søren Holm, Flemming L. Andersen and Liselotte Højgaard
    Journal of Nuclear Medicine March 1, 2012, 53 (3) 495-504; DOI: https://doi.org/10.2967/jnumed.111.095240

Book Review

  • You have access
    Clinical PET-CT in Radiology: Integrated Imaging in Oncology
    E. Edmund Kim
    Journal of Nuclear Medicine March 1, 2012, 53 (3) 505; DOI: https://doi.org/10.2967/jnumed.111.097535

Letters to the Editor

  • You have access
    Kinetic Analysis of 18F-FLT PET in Lung Tumors
    James R. Bading
    Journal of Nuclear Medicine March 1, 2012, 53 (3) 506; DOI: https://doi.org/10.2967/jnumed.111.097816
  • You have access
    Reply: Kinetic Analysis of 18F-FLT PET in Lung Tumors
    James Scott Brockenbrough and Hubert Vesselle
    Journal of Nuclear Medicine March 1, 2012, 53 (3) 506-507; DOI: https://doi.org/10.2967/jnumed.111.097873

Errata

  • You have access
    Errata
    Journal of Nuclear Medicine March 1, 2012, 53 (3) 507;
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 53 (3)
Journal of Nuclear Medicine
Vol. 53, Issue 3
March 1, 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Issue highlights

  • Impact of 3,4-Dihydroxy-6-18F-Fluoro-l-Phenylalanine PET/CT on Managing Patients with Brain Tumors: The Referring Physician's Perspective
  • Bringing Physiology into PET of the Liver
  • Experimental Radionuclide Therapy of HER2-Expressing Xenografts Using Two-Step Targeting Nuclisome Particles
Sign up for alerts

Jump to

  • This Month in JNM
  • SNM Newsline
  • Focus on Molecular Imaging
  • Invited Perspective
  • Clinical Investigations
  • Continuing Education
  • Basic Science Investigations
  • Book Review
  • Letters to the Editor
  • Errata
  • Most Cited
  • Most Read
Loading
  • First-in-Human Assessment of 11C-LSN3172176, an M1 Muscarinic Acetylcholine Receptor PET Radiotracer
  • Performance Evaluation of the uEXPLORER Total-Body PET/CT Scanner Based on NEMA NU 2-2018 with Additional Tests to Characterize PET Scanners with a Long Axial Field of View
  • Slow but Evident Recovery from Neocortical Dysfunction and Cognitive Impairment in a Series of Chronic COVID-19 Patients
  • Tumor Response to Radiopharmaceutical Therapies: The Knowns and the Unknowns
  • Is FDG maximum standardized uptake value (SUV max) of primary breast cancer can predict axillary lymph node metastasis?
More...
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire